drugset / Trial / NCT01673932
Safety and Feasibility Study of Umbilical Cord Blood Mononuclear Cells Transplant to Treat Ischemic Stroke
Phase 1
Unknown
12 enrolled
China Spinal Cord Injury Network
Chinese University of Hong Kong · collabPrince of Wales Hospital, Shatin, Hong Kong · collabQueen Mary Hospital, Hong Kong · collabStemCyte, Inc. · collabThe University of Hong Kong · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The study is to assess the safety and possible efficacy of umbilical cord blood mononuclear cells (UCBMC) treatment of chronic ischemic stroke.
Timeline
- Start
- 2012-10
- Primary completion
- 2018-12
- Completion
- 2019-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | umbilical cord blood mononuclear cells | Cell therapy | 1e+07 cells | Other |
| Subject | umbilical cord blood mononuclear cells | Cell therapy | 4e+07 cells | Other |